Sign in
Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
2022
Brolucizumab: Will it Make a Differance
Andrew P. Schachat, MD
2018
Category: AMD-Neovascular